Abstract

BackgroundWhole brain radiotherapy (WBRT) has been the treatment of choice for patients with brain metastases. However, change/decline of neurocognitive functions (NCFs) resulting from impaired hippocampal neurogenesis might occur after WBRT. It is reported that conformal hippocampal sparing would provide the preservation of NCFs. Our study aims to investigate the hippocampal dosimetry and to demonstrate the correlation between hippocampal dosimetry and neurocognitive outcomes in patients receiving hippocampal sparing during WBRT (HS-WBRT).MethodsForty prospectively recruited cancer patients underwent HS-WBRT for therapeutic or prophylactic purposes. Before receiving HS-WBRT, all participants received a battery of baseline neurocognitive assessment, including memory, executive functions and psychomotor speed. The follow-up neurocognitive assessment at 4 months after HS-WBRT was also performed. For the delivery of HS-WBRT, Volumetric Modulated Arc Therapy (VMAT) with two full arcs and two non-coplanar partial arcs was employed. For each treatment planning, dose volume histograms were generated for left hippocampus, right hippocampus, and the composite hippocampal structure respectively. Biologically equivalent doses in 2-Gy fractions (EQD2) assuming an alpha/beta ratio of 2 Gy were computed. To perform analyses addressing the correlation between hippocampal dosimetry and the change in scores of NCFs, pre- and post-HS-WBRT neurocognitive assessments were available in 24 patients in this study.ResultsScores of NCFs were quite stable before and after HS-WBRT in terms of hippocampus-dependent memory. Regarding verbal memory, the corresponding EQD2 values of 0, 10, 50, 80 % irradiating the composite hippocampal structure with <12.60 Gy, <8.81, <7.45 Gy and <5.83 Gy respectively were significantly associated with neurocognitive preservation indicated by the immediate recall of Word List Test of Wechsler Memory Scale-III. According to logistic regression analyses, it was noted that dosimetric parameters specific to left sided hippocampus exerted an influence on immediate recall of verbal memory (adjusted odds ratio, 4.08; p-value, 0.042, predicting patients’ neurocognitive decline after receiving HS-WBRT).ConclusionsFunctional preservation by hippocampal sparing during WBRT is indeed achieved in our study. Providing that modern VMAT techniques can reduce the dose irradiating bilateral hippocampi below dosimetric threshold, patients should be recruited in prospective trials of hippocampal sparing during cranial irradiation to accomplish neurocognitive preservation while maintaining intracranial control.Trial registrationCurrent Controlled Trials NCT02504788Electronic supplementary materialThe online version of this article (doi:10.1186/s13014-015-0562-x) contains supplementary material, which is available to authorized users.

Highlights

  • Whole brain radiotherapy (WBRT) has been the treatment of choice for patients with brain metastases

  • Providing that modern Volumetric Modulated Arc Therapy (VMAT) techniques can reduce the dose irradiating bilateral hippocampi below dosimetric threshold, patients should be recruited in prospective trials of hippocampal sparing during cranial irradiation to accomplish neurocognitive preservation while maintaining intracranial control

  • Patient selection Patients with primary lung cancer referred for prophylactic cranial irradiation (PCI) or adults with pathologically-confirmed non-hematopoietic malignancy and brain metastasis who had fair to good performance status represented by Karnofsky Performance Status (KPS) score 70 or Eastern Cooperative Oncology Group (ECOG) score 2 were eligible for this study

Read more

Summary

Introduction

Whole brain radiotherapy (WBRT) has been the treatment of choice for patients with brain metastases. Whole brain radiation (WBRT) with or without surgical resection has ever been the treatment of choice for patients with solitary brain metastasis and WBRT alone for those with multiple brain metastases; WBRT has long been a practical therapeutic modality for various settings of management in radiation oncology [2, 3]. Neurocognitive decline occurs within the first one to four months after the patient receives the course of WBRT for brain metastases [6]. According to the study reported by Sun et al [7], verbal memory function was most likely to deteriorate significantly after whole brain irradiation; general nonspecific cognitive functions and quality of life were not adversely influenced after receiving

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call